Marc Frahm
Analyst
Cowen and Company
Analyst
TD Cowen
Head of Investor Relations
Agios Pharmaceuticals, Inc. (AGIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marc Frahm
Marc Frahm is recorded as Analyst at Cowen and Company, Analyst at TD Cowen and Head of Investor Relations at Agios Pharmaceuticals, Inc. (AGIO). Marc Frahm has spoken on 1 earnings call across 1 company, most recently for Emergent BioSolutions Inc. on May 5, 2016.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cowen and Company
Analyst
Source not stated
Current -
TD Cowen
Analyst
Source not stated
Current -
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Agios Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Goff CEO, Board Member
- Jacqualyn Fouse CEO, Board Member
- David P. Schenkein Chairman
- Jacqualyn A. Fouse Chairman
- Cecilia Jones CFO
- T.J. Washburn Chief Accounting Officer
- Catherine Owen Adams Board Member
- Cynthia Smith Board Member
- David Scadden Board Member
- David Scadden, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.